Metformin to Prevent Anthracycline Cardiotoxicity?: That Would Be Sweet!

por El-Rayes, Malak, Nadler, Michelle B., Abdel-Qadir, Husam
Publicado 2023

Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations

por Wilson, Brooke E., Desnoyers, Alexandra, Nadler, Michelle B., Tibau, Ariadna, Amir, Eitan
Publicado 2021

A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time

por Wilson, Brooke E., Desnoyers, Alexandra, Al-Showbaki, Laith, Nadler, Michelle B., Amir, Eitan
Publicado 2022

Towards a Postgraduate Oncology Training Model for Family Medicine: Mixed Methods Evaluation of a Breast Oncology Rotation

por Nadler, Michelle B., Hofbauer, Brooke E., Wu, Melinda, Hum, Susan, Elser, Christine, Nyhof-Young, Joyce
Publicado 2022

Influence of Competing Risks on Estimates of Recurrence Risk and Breast Cancer-specific Mortality in Analyses of the Early Breast Cancer Trialists Collaborative Group

por Saleh, Ramy R., Nadler, Michelle B., Desnoyers, Alexandra, Rodin, Danielle L., Abdel-Qadir, Husam, Amir, Eitan
Publicado 2020

Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid Cancers

por Al-Showbaki, Laith, Nadler, Michelle B., Desnoyers, Alexandra, Almugbel, Fahad A., Cescon, David W., Amir, Eitan
Publicado 2021

Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49

por Nadler, Michelle B., Corrado, Ann Marie, Wilson, Brooke E., Desnoyers, Alexandra, Amir, Eitan, Ivers, Noah, Desveaux, Laura
Publicado 2023

Determinants of guideline-concordant breast cancer screening by family physicians for women aged 40–49 years: a qualitative analysis

por Nadler, Michelle B., Corrado, Ann Marie, Desveaux, Laura, Neil-Sztramko, Sarah E., Wilson, Brooke E., Desnoyers, Alexandra, Amir, Eitan, Ivers, Noah
Publicado 2022